Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | CAR-T treatment outcomes: MM real-world data

With two regularly approved CD19 CAR T-cell treatments, Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, speaks on the importance of real-world data. So far, there are comparable side effects in terms of cytokine release syndrome, neurotoxicity, as well as, clinical response. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.